Impel press release
Witryna11 kwi 2024 · Highlights Include Multiple Presentations Addressing Safety and Efficacy of TrudhesaSEATTLE, April 11, 2024 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals... Impel Pharmaceuticals to Present Data on Trudhesa® Nasal Spray for Treatment of Acute Migraine at 2024 American Academy of Neurology Annual Meeting - NXT Life … WitrynaThis morning we're reporting our Q4 & full year 2024 financial results and providing a business update. Join our live webcast TODAY at 8:30am ET to discuss them. Read our press release to learn ...
Impel press release
Did you know?
Witryna25 kwi 2024 · SEATTLE, April 25, 2024 (GLOBE NEWSWIRE) -- Impel NeuroPharma (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with... WitrynaImpel Pharmaceuticals is actively considering partnerships, collaborations and licensing opportunities to explore the therapeutic potential of our technology and expertise with … Impel Pharmaceuticals’ mission is to create and provide transformative therapies for … Impel Pharmaceuticals has developed a proprietary drug delivery technology … The efficacy of currently approved DHE-based medications is well-established … Impel INP105 – Acute Treatment of Agitation and Aggression in Autism … Impel Pharmaceuticals is currently developing INP107, a non-invasive, self- … impel pharmaceuticals has developed its proprietary Precision Olfactory Delivery … Archive of posts categorized by Publications in Impel Pharmaceuticals. Impel … Impel attended the 2024 Headache Cooperative of the Pacific’s 14th Annual …
Witryna15 sie 2024 · SEATTLE, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, today reported financial results for the second quarter ended June 30, 2024 … Witryna22 lut 2024 · SEATTLE, March 03, 2024 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage pharmaceutical company …
Witryna18 sty 2024 · This press release contains “forward-looking” statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including, but not limited to, the potential clinical benefits of Trudhesa™, the market opportunities of Trudhesa within the migraine market, the speed of uptake and … Witryna25 kwi 2024 · SEATTLE, April 25, 2024 (GLOBE NEWSWIRE) -- Impel NeuroPharma (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, today announced that it is changing its name to Impel Pharmaceuticals.
WitrynaThe Impel Platform; Merchandising; Communication; Imaging; Enterprise Developer Cloud; Integrations; Solutions. Dealership Groups; Local Auto Dealers; Specialty …
Witryna11 kwi 2024 · SEATTLE, April 11, 2024 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, announced today that four Trudhesa ® (dihydroergotamine mesylate) nasal … lila althea fenwickWitryna12 kwi 2024 · SEATTLE, April 12, 2024 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, today announced the appointment of Darren Cline to the Board of Directors. … hotels in blythe azhotels in blue mound illinoisWitryna17 mar 2024 · SEATTLE, March 17, 2024 (GLOBE NEWSWIRE) -- Impel NeuroPharma (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with... lila activewearWitryna9 wrz 2024 · Sep 09, 2024. PDF Version. SEATTLE, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Impel NeuroPharma, Inc. (NASDAQ: IMPL), a commercial-stage … lil 2z wallpaperWitrynaSEATTLE, Sept. 09, 2024 (GLOBE NEWSWIRE) — Impel NeuroPharma, Inc. (NASDAQ: IMPL), a commercial-stage biopharmaceutical company developing … lil 9 deathWitryna12 kwi 2024 · SEATTLE, April 12, 2024 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing … lila abu-lughod writing against culture